May 15, 2017 / 8:40 PM / in 5 months

BRIEF-Capricor Therapeutics Q1 loss per share $0.17

May 15 (Reuters) - Capricor Therapeutics Inc

* Capricor Therapeutics reports first quarter 2017 financial results and provides corporate update

* Q1 loss per share $0.17

* As of March 31, 2017, company’s cash, cash equivalents and marketable securities totaled approximately $11.7 million

* Believes current financial resources should be sufficient to fund its operations and meet its financial obligations through Q1 of 2018

* Investigational new drug application (IND) for CAP-2003 expected to be submitted in 2018 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below